BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 27933492)

  • 1. Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson's disease.
    Rusz J; Tykalová T; Krupička R; Zárubová K; Novotný M; Jech R; Szabó Z; Růžička E
    J Neural Transm (Vienna); 2017 Apr; 124(4):463-470. PubMed ID: 27933492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients.
    Rusz J; Tykalová T; Klempíř J; Čmejla R; Růžička E
    J Neural Transm (Vienna); 2016 Apr; 123(4):379-87. PubMed ID: 26843071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Speech and voice disorders in Parkinson's disease].
    Martnez-Sánchez F
    Rev Neurol; 2010 Nov; 51(9):542-50. PubMed ID: 20979034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease.
    Rusz J; Cmejla R; Ruzickova H; Ruzicka E
    J Acoust Soc Am; 2011 Jan; 129(1):350-67. PubMed ID: 21303016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tests of manual dexterity and speed in Parkinson's disease: Not all measure the same.
    Růžička E; Krupička R; Zárubová K; Rusz J; Jech R; Szabó Z
    Parkinsonism Relat Disord; 2016 Jul; 28():118-23. PubMed ID: 27185294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease.
    Pawlukowska W; Gołąb-Janowska M; Safranow K; Rotter I; Amernik K; Honczarenko K; Nowacki P
    Neurol Neurochir Pol; 2015; 49(5):302-6. PubMed ID: 26377981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
    J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of dysprosody in Parkinson's disease over time--a longitudinal study.
    Skodda S; Rinsche H; Schlegel U
    Mov Disord; 2009 Apr; 24(5):716-22. PubMed ID: 19117364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Voice and Motor Disabilities of Parkinson's Disease.
    Majdinasab F; Karkheiran S; Soltani M; Moradi N; Shahidi G
    J Voice; 2016 Nov; 30(6):768.e17-768.e22. PubMed ID: 26725551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acoustic investigation of stress patterns in Parkinson's disease.
    Tykalova T; Rusz J; Cmejla R; Ruzickova H; Ruzicka E
    J Voice; 2014 Jan; 28(1):129.e1-129.e8. PubMed ID: 24094802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy.
    Rusz J; Cmejla R; Růžičková H; Klempíř J; Majerová V; Picmausová J; Roth J; Růžička E
    J Neural Transm (Vienna); 2013 Feb; 120(2):319-29. PubMed ID: 22772465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation.
    Brabenec L; Mekyska J; Galaz Z; Rektorova I
    J Neural Transm (Vienna); 2017 Mar; 124(3):303-334. PubMed ID: 28101650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. For better or worse: The effect of levodopa on speech in Parkinson's disease.
    Ho AK; Bradshaw JL; Iansek R
    Mov Disord; 2008 Mar; 23(4):574-80. PubMed ID: 18163453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speech disorders in Parkinson's disease: pathophysiology, medical management and surgical approaches.
    Dashtipour K; Tafreshi A; Lee J; Crawley B
    Neurodegener Dis Manag; 2018 Oct; 8(5):337-348. PubMed ID: 30223711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mirror movements in Parkinson's disease: An under-appreciated clinical sign.
    Chatterjee P; Banerjee R; Choudhury S; Mondal B; Kulsum MU; Chatterjee K; Kumar H
    J Neurol Sci; 2016 Jul; 366():171-176. PubMed ID: 27288800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
    Goberman AM
    Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acoustic evaluation of short-term effects of repetitive transcranial magnetic stimulation on motor aspects of speech in Parkinson's disease.
    Eliasova I; Mekyska J; Kostalova M; Marecek R; Smekal Z; Rektorova I
    J Neural Transm (Vienna); 2013 Apr; 120(4):597-605. PubMed ID: 23254927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Levodopa on Vowel Articulation in Patients with Parkinson's Disease.
    Okada Y; Murata M; Toda T
    Kobe J Med Sci; 2015 Apr; 61(5):E144-54. PubMed ID: 27363398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-related patterns of dysprosody in Parkinson disease and correlation between speech variables and motor symptoms.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Jan; 25(1):76-82. PubMed ID: 20381998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prominence marking in parkinsonian speech and its correlation with motor performance and cognitive abilities.
    Thies T; Mücke D; Lowit A; Kalbe E; Steffen J; Barbe MT
    Neuropsychologia; 2020 Feb; 137():107306. PubMed ID: 31857118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.